← The Wire
FATENasdaq
FATE THERAPEUTICS INC
Biological Products, (No Diagnostic Substances) · CIK 1434316
Develops off-the-shelf cellular immunotherapies from engineered stem cells for broad patient access
red 8-K · 90d
$240M
Market cap
$2.42
Last close
+15.2%
1D
+12.6%
5D
5.9M
Volume
Price · last 39 sessions+34.4%
May 4L $1.73 · H $2.84Jun 29
249
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 15, 20268-KCompany UpdateJun 4, 20268-KResults of OperationsMay 13, 20268-KResults of OperationsFeb 26, 20268-KResults of OperationsNov 13, 20258-KReg FD Disclosure · Company UpdateOct 27, 20258-KExecutive Change · Reg FD DisclosureOct 14, 20258-KResults of Operations · Exit / Disposal CostsAug 12, 20258-KExecutive Change · Bylaw AmendmentMay 30, 20258-KResults of OperationsMay 13, 20258-KResults of OperationsMar 5, 20258-KExecutive ChangeJan 6, 20258-KExecutive Change · Reg FD DisclosureNov 29, 20248-KResults of OperationsNov 12, 20248-KExecutive Change · Material AgreementAug 30, 20248-KResults of OperationsAug 13, 20248-KExecutive Change · Reg FD DisclosureJul 31, 20248-KBylaw AmendmentJun 10, 20248-KExecutive Change · Shareholder VoteJun 7, 20248-KExecutive ChangeMay 31, 20248-KResults of OperationsMay 9, 20248-KReg FD Disclosure · Company UpdateMay 9, 20248-KMaterial Agreement · Equity IssuanceMar 21, 20248-KResults of OperationsFeb 26, 20248-KMaterial Agreement · Agreement TerminatedNov 8, 20238-KResults of OperationsNov 8, 20238-KCompany UpdateSep 1, 20238-KResults of OperationsAug 8, 20238-KShareholder VoteJun 9, 20238-KExecutive ChangeJun 8, 20238-KCompany UpdateJun 7, 20238-KResults of OperationsMay 3, 20238-KDelisting Notice · Bylaw AmendmentApr 19, 20238-KResults of OperationsFeb 28, 20238-KExecutive Change · Agreement TerminatedJan 5, 20238-KMaterial Agreement · Reg FD DisclosureNov 7, 20228-KResults of OperationsNov 3, 20228-KResults of OperationsAug 3, 20228-KMaterial Agreement · Reg FD DisclosureJun 30, 20228-KExecutive Change · Shareholder VoteJun 13, 20228-KResults of OperationsMay 4, 20228-KResults of OperationsFeb 28, 20228-KCompany UpdateDec 14, 20218-KMaterial Agreement · Agreement TerminatedNov 4, 20218-KResults of OperationsNov 4, 20218-KResults of OperationsAug 4, 20218-KExecutive Change · Reg FD DisclosureAug 4, 20218-KBylaw Amendment · Shareholder VoteJun 7, 20218-KResults of OperationsMay 5, 20218-KExecutive ChangeMar 25, 20218-KResults of OperationsFeb 24, 20218-KMaterial Agreement · Company UpdateJan 8, 20218-KBylaw AmendmentDec 22, 20208-KCompany UpdateDec 7, 20208-KResults of OperationsNov 5, 20208-KExecutive Change · Bylaw AmendmentAug 19, 20208-KResults of OperationsAug 5, 20208-KMaterial Agreement · Equity IssuanceJun 10, 20208-KResults of OperationsMay 11, 20208-KExecutive Change · Shareholder VoteMay 5, 20208-KCompany UpdateApr 28, 20208-KMaterial Agreement · Equity IssuanceApr 2, 20208-KResults of OperationsMar 2, 20208-KMaterial Agreement · New Debt / ObligationJan 10, 20208-KAgreement TerminatedNov 14, 20198-KResults of OperationsNov 5, 20198-KMaterial Agreement · Company UpdateSep 13, 20198-KResults of OperationsAug 6, 20198-KExecutive Change · Reg FD DisclosureJul 17, 20198-KResults of OperationsMay 7, 20198-KShareholder VoteMay 7, 20198-KExecutive Change · Reg FD DisclosureMar 18, 20198-KResults of OperationsMar 5, 20198-KCompany UpdateJan 4, 20198-KMaterial AgreementNov 21, 20188-KExecutive ChangeNov 7, 20188-KResults of OperationsNov 1, 20188-KMaterial Agreement · Company UpdateSep 21, 20188-KMaterial Agreement · Reg FD DisclosureSep 18, 20188-KMaterial Agreement · Reg FD DisclosureSep 13, 2018
Insider Activity
In the 90 days to Jan 9, 2026: 2 sold $17K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Tahl CindySee Remarks | Sell | 10,589 | $1.06 | $11K |
| Jan 9, 2026 | Valamehr BahramPresident and CEO | Sell | 5,190 | $1.07 | $6K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance